Polyunsaturated fatty acids synergize with lipid droplet binding thalidomide analogs to induce oxidative stress in cancer cells
Authors:
- László G PuskásLászló G Puskás
- Liliána Z FehérLFLiliána Z Fehér
- Csaba VizlerCVCsaba Vizler
- Ferhan AyaydinFAFerhan Ayaydin
- Erzsébet RásóERErzsébet Rásó
- Eszter MolnárEMEszter Molnár
- István MagyaryIMIstván Magyary
- Iván KanizsaiIKIván Kanizsai
- Márió GyurisMGMárió Gyuris
- Ramóna MadácsiRMRamóna Madácsi
- Gabriella FábiánGFGabriella Fábián
- Klaudia FarkasKFKlaudia Farkas
Open Access
- 1 January 2010
- journal article
- research article
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 9 (1) , 56
Abstract
Cytoplasmic lipid-droplets are common inclusions of eukaryotic cells. Lipid-droplet binding thalidomide analogs (2,6-dialkylphenyl-4/5-amino-substituted-5,6,7-trifluorophthalimides) with potent anticancer activities were synthesized. Cytotoxicity was detected in different cell lines including melanoma, leukemia, hepatocellular carcinoma, glioblastoma at micromolar concentrations. The synthesized analogs are non-toxic to adult animals up to 1 g/kg but are teratogenic to zebrafish embryos at micromolar concentrations with defects in the developing muscle. Treatment of tumor cells resulted in calcium release from the endoplasmic reticulum (ER), induction of reactive oxygen species (ROS), ER stress and cell death. Antioxidants could partially, while an intracellular calcium chelator almost completely diminish ROS production. Exogenous docosahexaenoic acid or eicosapentaenoic acid induced calcium release and ROS generation, and synergized with the analogs in vitro, while oleic acid had no such an effect. Gene expression analysis confirmed the induction of ER stress-mediated apoptosis pathway components, such as GADD153, ATF3, Luman/CREB3 and the ER-associated degradation-related HERPUD1 genes. Tumor suppressors, P53, LATS2 and ING3 were also up-regulated in various cell lines after drug treatment. Amino-phthalimides down-regulated the expression of CCL2, which is implicated in tumor metastasis and angiogenesis. Because of the anticancer, anti-angiogenic action and the wide range of applicability of the immunomodulatory drugs, including thalidomide analogs, lipid droplet-binding members of this family could represent a new class of agents by affecting ER-membrane integrity and perturbations of ER homeostasis.Keywords
This publication has 41 references indexed in Scilit:
- Zebrafish embryos as models for embryotoxic and teratological effects of chemicalsReproductive Toxicology, 2009
- Rab-regulated interaction of early endosomes with lipid dropletsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- A possible cellular explanation for the NMR-visible mobile lipid (ML) changes in cultured C6 glioma cells with growthBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Selective leukemic-cell killing by a novel functional class of thalidomide analogsBlood, 2006
- A thalidomide analogue within vitroantiproliferative, antimitotic, and microtubule-stabilizing activitiesMolecular Cancer Therapeutics, 2006
- From acute ER stress to physiological roles of the Unfolded Protein ResponseCell Death & Differentiation, 2006
- Cholesterol and cholesterol plus DHA diet-induced gene expression and fatty acid changes in mouse eye and brainBiochimie, 2004
- Sorting nexin 16 regulates EGF receptor trafficking by phosphatidylinositol-3-phosphate interaction with the Phox domainJournal of Cell Science, 2004
- A Role for Sorting Nexin 2 in Epidermal Growth Factor Receptor Down-regulation: Evidence for Distinct Functions of Sorting Nexin 1 and 2 in Protein TraffickingMolecular Biology of the Cell, 2004
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994